Evidence map›Paper›PMID 25165983›Full record

ArticlePloS one2014

Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma.

Weiyuan Wang, Qiuyuan Wen, Lina Xu, Guiyuan Xie, Jiao Li, Jiadi Luo, Shuzhou Chu, Lei Shi, Donghai Huang, Jinghe Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Roles of THEM4 in the Akt pathway: a double-edged sword.Journal of Zhejiang University. Science. B · 2024
    Review
  6. Tumor biomarkers for diagnosis, prognosis and targeted therapy.Signal transduction and targeted therapy · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Weiyuan WangDepartment of Pathology, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Qiuyuan WenDepartment of Pathology, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Lina XuDepartment of Pathology, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Guiyuan XieDepartment of Oncology, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Jiao LiDepartment of Pathology, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Jiadi LuoDepartment of Pathology, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Shuzhou ChuDepartment of Pathology, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Lei ShiDepartment of Pathology, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Donghai HuangDepartment of Otorhinolaryngology, Xiangya Hospital of Central South University, Changsha, Hunan, China.
Jinghe LiDepartment of Pathology, Basic Medical College of Central South University, Changsha, Hunan, China.
Songqing FanDepartment of Pathology, the Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nasopharyngeal carcinoma (NPC) is a malignant tumor of the head and neck region, which frequently occurs in Southeast Asia, especially in the south of China. It is known that the mammalian target of rapamycin (mTOR) pathway plays a central role in regulating cellular functions, including proliferation, growth, survival, mobility, and angiogenesis. Aberrant expression of the mTOR signaling pathway molecules has been found in many types of cancer. However, whether the alterations of p-Akt, p-p70S6K and p-4EBP1 protein expression are associated with clinicopathological features and prognostic implications in NPC have not been reported. The purposes of the present study are to investigate the association between the expression of p-Akt, p-p70S6K and p-4EBP1 proteins and clinicopathological features in NPC by immunohistochemistry. The results showed that the positive percentage of p-Akt, p-p70S6K and p-4EBP1 proteins expression in NPC (47.2%, 73.0% and 61.7%, respectively) was significantly higher than that in the non-cancerous nasopharyngeal control tissue (33.3%, 59.1% and 47.0%, respectively). There was a significantly higher positive expression of p-Akt in undifferentiated non-keratinizing nasopharyngeal carcinoma than that in differentiated non-keratinizing nasopharyngeal carcinoma (P = 0.014). Additionally, positive expression of p-p70S6K and p-4EBP1 proteins, and positive expression of either of p-Akt, p-p70S6K and p-4EBP1 were significantly correlated inversely with overall survival rates of NPC patients (P = 0.023, P = 0.033, P = 0.008, respectively). Spearman's rank correlation test showed that expression of p-Akt in NPC was significantly associated with expression of p-p70S6K (r = 0.263, P<0.001) and p-4EBP1(r = 0.284, P<0.001). Also there was an obviously positive association between expression of p-p70S6K and p-4EBP1 proteins in NPC (r = 0.286, P<0.001). Multivariate Cox regression analysis further identified positive expression of p-4EBP1 and p-p70S6K proteins were the independent poor prognostic factors for NPC (P = 0.043, P = 0.027, respectively). Taken together, high expression of p-p70S6K and p-4EBP1 proteins may act as valuable independent biomarkers to predict a poor prognosis of NPC.

Indexed as

Adaptor Proteins, Signal TransducingAdolescentAdultAgedCarcinomaCell Cycle ProteinsChinaFemaleHumansMaleMiddle AgedNasopharyngeal CarcinomaNasopharyngeal NeoplasmsPhosphoproteinsPhosphorylationPrognosisAdaptor Proteins, Signal TransducingCell Cycle ProteinsEIF4EBP1 protein, humanMTOR protein, humanPhosphoproteinsProto-Oncogene Proteins c-aktribosomal protein S6 kinase, 70kD, polypeptide 1Ribosomal Protein S6 Kinases, 70-kDaTOR Serine-Threonine Kinases

Identifiers

PMID25165983
PMCPMC4148345
OpenAlexW2033251175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.